BrightPoint, Inc. (CELL) Is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of BrightPoint, Inc. ("BrightPoint" or the “Company”) (NASDAQ: CELL) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Ingram Micro Inc. (NYSE: IM) in an all-cash deal valued at approximately $895.02 million. Under the terms of the proposed transaction, BrightPoint stockholders will receive $9 in cash for each share of BrightPoint they own, while according to Yahoo! Finance, at least one financial analyst has set a price target of $12 for BrightPoint.